These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 9112671)
1. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients. Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671 [TBL] [Abstract][Full Text] [Related]
2. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk]. Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826 [TBL] [Abstract][Full Text] [Related]
3. Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients. Janicki K; Dmoszyńska A; Janicka L; Stettner S; Jesipowicz J Int Urol Nephrol; 1992; 24(1):83-9. PubMed ID: 1624248 [TBL] [Abstract][Full Text] [Related]
4. Comparison of aspirin and indobufen in healthy volunteers. Lee JY; Sung KC; Choi HI Platelets; 2016; 27(2):105-9. PubMed ID: 26083594 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
6. A prostacyclin-sparing effect of indobufen vs. aspirin. De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417 [TBL] [Abstract][Full Text] [Related]
7. [Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)]. Jacques C; Drueke T; Nedellec J; Kremp O; Gazengel C Pathol Biol (Paris); 1976 Dec; 24 Suppl():27-32. PubMed ID: 827731 [TBL] [Abstract][Full Text] [Related]
8. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis]. Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347 [TBL] [Abstract][Full Text] [Related]
9. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196 [TBL] [Abstract][Full Text] [Related]
10. [Treatment with indobufen of platelet hyperaggregation in a group of patients with vascular diseases]. Barbieri U; Cappelli S; Zaniol P; Righi A; Artusi P; Scorrano M Minerva Med; 1991; 82(1-2):63-7. PubMed ID: 2000177 [TBL] [Abstract][Full Text] [Related]
11. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo. Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363 [TBL] [Abstract][Full Text] [Related]
12. Indobufen induced modification of phospholipid composition in diabetic platelets. Dmoszyńska A; Sokołowska B; Walter-Croneck A; Przesmycki K; Ledwozyw A Pol J Pharmacol; 1996; 48(3):331-4. PubMed ID: 9112672 [TBL] [Abstract][Full Text] [Related]
13. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats. Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031 [TBL] [Abstract][Full Text] [Related]
14. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583 [TBL] [Abstract][Full Text] [Related]
15. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year]. Rohn V; Pirk J; Mach T Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942 [TBL] [Abstract][Full Text] [Related]
16. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424 [TBL] [Abstract][Full Text] [Related]
17. [Chronic treatment of vascular diseases with indobufen]. Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803 [TBL] [Abstract][Full Text] [Related]
18. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511 [TBL] [Abstract][Full Text] [Related]
19. Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease. Fabris F; Steffan A; Randi ML; Avruscio GP; Cordiano I; Girolami A J Med; 1992; 23(2):81-92. PubMed ID: 1512524 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]